Temozolomide
NDC 73043-014, Temozolomide, capsule, from Devatis, Inc..
- Product NDC
- 73043-014
- Status
- Listed
- Labeler
- Devatis, Inc.
- Dosage form
- CAPSULE
- Route
- ORAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- ANDA
- Application
- ANDA207658
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/73043-014 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- TEMOZOLOMIDE140 mg/1
Pharmacologic classes
Alkylating Activity [MoA]; Alkylating Drug [EPC]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 73043-014-05 | 73043001405 | 5 CAPSULE in 1 BOTTLE (73043-014-05) |
| 73043-014-14 | 73043001414 | 14 CAPSULE in 1 BOTTLE (73043-014-14) |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
FDA label sections
GET /v1/drugs/labels/6b263fe0-5f06-4889-bf14-4aa185470810
Use it
Look up 73043-014 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/73043-014 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 73043-014. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.